SHAREHOLDER STRUCTURE

Ibnsina Pharma’s shareholders include prominent members of the Egyptian business community and large institutional shareholders that have allowed the company to significantly enhance its corporate governance practices and systems. The company’s shareholders include the Mahgoub family (16.2%), the Abdel Gawad family (16.5%), the European Bank for Reconstruction and Development (EBRD) (10.1%), and Faisal Islamic Bank (12.6%). Other shareholders, including members of its senior management team, collectively (7.2%), and free float (37.4%).